[Federal Register Volume 77, Number 25 (Tuesday, February 7, 2012)]
[Notices]
[Pages 6057-6058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-2788]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 1810]


Approval for Manufacturing Authority, Foreign-Trade Zone 22, 
Baxter Healthcare Corporation, (Pharmaceutical and Biological 
Intravenous Product Manufacturing), Chicago, IL

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:

    Whereas, the Illinois International Port District, grantee of 
Foreign-Trade Zone 22, has requested manufacturing authority on behalf 
of Baxter Healthcare Corporation, within FTZ 22 in Round Lake, Illinois 
(FTZ Docket 60-2010, filed 10/15/2010);
    Whereas, notice inviting public comment has been given in the 
Federal Register (75 FR 65448, 10/25/2010) and the application has been 
processed pursuant to the FTZ Act and the Board's regulations; and
    Whereas, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied, and that the proposal is in the 
public interest;

[[Page 6058]]

    Now, therefore, the Board hereby orders:
    The application for manufacturing authority under zone procedures 
within FTZ 22 on behalf of Baxter Healthcare Corporation, as described 
in the application and Federal Register notice, is approved, subject to 
the FTZ Act and the Board's regulations, including Section 400.28.

    Signed at Washington, DC, this 31st day of January 2012.
Paul Piquado,
Assistant Secretary of Commerce for Import Administration, Alternate 
Chairman, Foreign-Trade Zones Board.

ATTEST:
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2012-2788 Filed 2-6-12; 8:45 am]
BILLING CODE 3510-DS-P